<DOC>
	<DOCNO>NCT03007186</DOCNO>
	<brief_summary>This study aim show whether hyperglycaemic phase follow treatment glucocorticoid , well blood measurement correlate high blood glucose level insulin resistance , vary significantly patient without gestational diabetes mellitus .</brief_summary>
	<brief_title>Glucose Monitoring During Threatening Preterm Birth Patients With Without Gestational Diabetes Mellitus</brief_title>
	<detailed_description>BACKGROUND : The therapy glucocorticoid fetal lung maturation case threaten preterm birth long exist part obstetric routine procedure . Under therapy forgotten , glucocorticoid lead decrease maternal insulin sensitivity well cause impaired maternal glucose tolerance . Therefore threaten preterm birth well include medical therapy challenge glucose metabolism mother child . Gestational diabetes mellitus ( GDM ) one common complication pregnancy , number rise . GDM characterize insulin resistance pregnancy . High blood glucose level pregnancy labour cause complication like fetal hypoglycaemia right birth . METHODS : This study include pregnant woman without gestational diabetes medicate betamethasone due threaten preterm birth . In study blood glucose measurement one week , well measurement HbA1C , Insulin Blood Glucose blood draw one week lung maturation therapy consider .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Hypersensitivity</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Diabetes , Gestational</mesh_term>
	<mesh_term>Glucose Intolerance</mesh_term>
	<criteria>female gestational age 23+0 34+6 oral glucose tolerance test make attests healthy glucose tolerance ( control group ) gestational diabetes mellitus ( case group ) threaten preterm birth miss consent participate age 18 year age 50 year preexistent diabetes ( type 1 2 ) apparent disease thyroid gland infectious disease HIV Hepatitis C insulin dependent gestational diabetes mellitus</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Blood glucose monitoring</keyword>
	<keyword>Glucose tolerance</keyword>
	<keyword>HbA1C</keyword>
	<keyword>Insulin</keyword>
	<keyword>Betamethasone</keyword>
</DOC>